Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade

肿瘤免疫抑制的昼夜节律控制影响免疫检查点阻断的疗效

阅读:5
作者:Bridget M Fortin ,Shannon M Pfeiffer ,Jacob Insua-Rodríguez ,Hamad Alshetaiwi ,Alexander Moshensky ,Wei A Song ,Alisa L Mahieu ,Sung Kook Chun ,Amber N Lewis ,Alex Hsu ,Isam Adam ,Oliver S Eng ,Nicholas R Pannunzio ,Marcus M Seldin ,Ivan Marazzi ,Francesco Marangoni ,Devon A Lawson ,Kai Kessenbrock ,Selma Masri

Abstract

The circadian clock is a critical regulator of immunity, and this circadian control of immune modulation has an essential function in host defense and tumor immunosurveillance. Here we use a single-cell RNA sequencing approach and a genetic model of colorectal cancer to identify clock-dependent changes to the immune landscape that control the abundance of immunosuppressive cells and consequent suppression of cytotoxic CD8+ T cells. Of these immunosuppressive cell types, PD-L1-expressing myeloid-derived suppressor cells (MDSCs) peak in abundance in a rhythmic manner. Disruption of the epithelial cell clock regulates the secretion of cytokines that promote heightened inflammation, recruitment of neutrophils and the subsequent development of MDSCs. We also show that time-of-day anti-PD-L1 delivery is most effective when synchronized with the abundance of immunosuppressive MDSCs. Collectively, these data indicate that circadian gating of tumor immunosuppression informs the timing and efficacy of immune checkpoint inhibitors.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。